A 44-year-old womansuffered from recurrent fever, edema and fatigue. Laboratory data revealed renal dysfunction, low proteinemia, disseminated intravascular coagulation (DIC) and myelodysplasia. A renal and lymph node biopsy showed a marked angiogenesis. Serum levels of vascular endothelial growth factor (VEGF), and interleukin (IL)-6 were markedly increased, suggesting a pathogenesis related to VEGF-inducedangiogenesis. The symptomswere remitted after treatment with cyclosporin A. No evidence of solid tumors, malignant lymphoma, Castleman's disease or POEMS(polyneuropathy, organomegaly, endocrine disorder, M-proteinemia and skin change) syndrome, reported to induce a high serum VEGFlevel, was obtained. This case mayhave involved an unknownmechanismwhich induced an overexpression of VEGFand IL-6.
Introduction
Capillary proliferation and vascular hyperpermeability in malignant tumors, diabetic retinopathy and rheumatoid arthritis are related to angiogenesis ( 1 ) . Recently, these diseases have been classified as "angiogenic diseases". Angiogenesis is enhanced by several cytokines including fibroblastic growth factor (FGF) , placental growth factor (PGF), interleukin (IL)-8 and VEGF.VEGFis the most relevant cytokine since its expression is closely correlated with vessel density in several human tumors. Inhibition of VEGFsupresses tumor growth (2) . We describe a patient with recurrent fever, systemic edema, renal failure, DIC, pleural effusion, pulmonary embolism and myelodysplasia possibly due to VEGF-induced angiogenesis via an unknownmechanism.
For editorial comment, see p 527.
Case Report
A 44-year-old womanwas admitted to our hospital on October 5, 1998, because of recurrent fever, prominent facial edema and fatigue. She was healthy before the onset of these symptoms.Onemonthbefore admission, she complained of facial edema, fever (>38°C), cough and fatigue. She took some commoncold medicine, but her symptoms did not improve, and she was admitted to another hospital for observation.
Laboratory data showed renal dysfunction (blood urea nitrogen, 37 mg/dl, creatinine (Cr), 2.4 mg/dl, urinary protein 3+, urinary occult blood 2+), low proteinemia (total protein, 5.2 g/dl) and increased C-reactive protein (CRP) (29.2 mg/dl).
Since oliguria and other symptomssuch as fever remained unchanged, she was transferred to our hospital. On admission, her height was 165.8 cm, and her body weight was 70 kg, which had increased by 10 kg in the previous month. Her body temperature was 37.8°C, blood pressure was 120/64 mmHg, pulse rate was regular at 90/min and her respiratory rate was 24/min. Lymphnode enlargement was not noted except for an elastic soft one in the left inguinal region 1 cm in diameter. A prominent facial and bilateral leg pitting edema was noted.
The laboratory data are shown in Table1. In brief, she had leukocytosis, renal dysfunction, high CRP and DIC. Immunoglobulin (IgG, IgA, IgM) level was normal. Antinuclear antibody was not detected, and complementswere within the normal range. Repeated cultures of sputum, blood, urine and pleu- Figure 1 . A radiograph of the chest on admission, showing bilateral vascular shadow enhancement in the lung field and massive bilateral pleural effusion. ral effusion were all negative for bacterium and mycobacterium. An assay of paired serum samples was negative for antibodies against EB virus. A urine examination revealed proteinuria (0.9 g/day) and hematuria.
The radiograph of the chest on admission and the computed tomographic (CT) scan demonstrated bilateral vascular shadow enhancement in the lung field and massive bilateral pleural effusion ( Fig. 1) . A CT of the abdomen showed hepatosplenomegaly, swelling of several small para-aortic lymph nodes and a small amount of ascites (Fig. 2) . The clinical course is shown in Fig. 3 . After admission, the recurrent fever (38~39°C) continued. Oliguria (less than 500 ml/day) continued despite the administration of diuretics. On October 9, she complained of dyspnea. Arterial blood gas analysis revealed hypoxemia (PaO2 54 mmHg, PaCO2 28 mmHg). An echocardiogramshowedenlargement of the right ventricle, and a massive thrombus was detected in the right pulmonary artery. She was diagnosed with pulmonary embolism and transferred to ICU. At the same time, heparin (20,000 U/day) was administered continuously because she also had DIC. She recovered from respiratory dysfunction, but her urine volume decreased day by day. Hemodialysis was performed from October 10 due to acute renal failure. guinal lymph node (Figs. 4, 5) . Swelling of endocapillary cells and proliferation of the capillary were commonlyobserved in both tissues. The kidney specimen showed endocapillary glomerulonephritis. Fromthese results, we suspected the presence of stimulated angiogenesis due to an overproduction of cytokines through someunknownmechanisms.Wemeasured serum VEGF, and detected a very high level (7,430 pg/ml, normal range is <100 pg/ml). IL-6 was also increased (60 pg/ml, normal range is <5 pg/ml). ILl-p was 24 pg/ml (normal range is <30 pg/ml). TNF-a was less than 5 pg/ml (normal range is <5 pg/ml). We could not find any evidence of solid tumors, malignant lymphoma, acute myeloid leukemia, Castleman's disease or POEMS syndrome. While she was in the hospital, anemia and thrombocytopenia gradually progressed. Bone marrowaspirates showed slight hypocellularity, and myelodysplastic changes such as pseudoPelger-Huet anomaly, hypersegmentation of neutrophils, giant platelets, megakaryocytes with single or multiple round nuclei, erythroid multinucleation and delayed and distorted nuclear and cytoplasmic maturation were noted (Fig. 6 ). These findings led to the diagnosis of myelodysplastic syndrome (MDS). Wesuspected infection, collagen disease and/or malignancy pulse therapy (methylprednisolone at doses of 500 mg/day) was administered for inflammation due to hypercytokinemia for 3 days, being tapered thereafter. Despite repeated trials, steroid therapy had only a transient effect on the clinical problems such as high fever and renal failure. Therefore, we decided to administer other immuno-suppressivedrugs against hypercytokinemia. We started cyclosporin A from November 14. Weadjusted the dose of cyclosporin A to maintain the serum level between 100 and 150 ng/ml as the trough level. After one month, her urine volume gradually increased and the fever recovered. The serum VEGFmarkedly decreased. Most of her symptoms improved, and on February 28, 1999, she was discharged. She maintains good physical condition without recurrence, taking 200 mg of cyclosporin A daily.
Discussion
In this report we described a patient with a variety of symptoms such as recurrent fever, renal failure and lymphadenopathy. A biopsy specimen obtained from kidney and lymph nodes revealed swelling of endocapillary cells and proliferation of the capillary vessels without showingany evidence specific to a knowndisease. These findings suggested a reactive change of an overproduction of cytokines, enhancing angiogenesis. Therefore we measured serum VEGF,and found a very high level (7,430 pg/ml). In previous clinical case reports, high serumVEGF levels were observed in some diseases such as solid tumor (3), malignant lymphoma (4), acute myeloid leukemia (5), Castleman' s disease (6) and POEMSsyndrome (7). It has been reported that FGF, platelet-derived endothelial cell growth factor, angiogenin, epidermal growth factor and insulin-like growth factor-1 are regulators of angiogenesis (2) . In addition to these factors, VEGF is also a major regulator of angiogenesis. Whenchronic stimulation of VEGFcontinues systemically, vascular hyperpermeability and thrombosis may be induced. There are many other cytokines to induce angiogenosis, such as hepatocyte growth factor, PGFor IL-8. However, we did not measure these cytokines in this patient. Arimura et al reported two patients with POEMS syndrome complicated with solitary myeloma that showed a very high serum VEGFlevel (8) . He speculated that a high level of serum VEGFwas the primary pathogenesis of POEMS syndrome. Plasma cells (9) and macrophages ( 10) are candidates of VEGF production sites. In our patient, there was no evidence of POEMSsyndrome, such as polyneuropathy, organomegaly, endocrinopathy, M-proteinemia or skin change.
Initially, we suspected the hyaline vascular type of
Castleman's disease (1 1) because a hypervascular lesion with hyalinization in lymph nodes was noted. However, we considered this to be atypical because she had systemic symptoms such as fever, an increase of acute inflammatory proteins like CRP, fibrinogen, IL-6 and renal failure. These findings were more compatible with the plasma cell type of Castleman's disease rather than the hyaline vascular type (12) , although her clinical features did not fit this disease.
Another interesting finding was that bone marrow showed a myelodysplastic change. In a literature search, we could not find any reports of patients with an increased level of VEGF accompanied with MDS. Angioblasts, differentiated from mesodermal cells by hemangioblasts during embryonic development, are organized to form a primitive vascular network. Hemopoieticstem cells are also differentiated from hemangioblasts (1 3, 14) . Namely, both angioblasts and stem cells are the progeny of the same hemopoietic stem cells. They have a commonantigen, the tyrosine kinase receptor family (Flk-1, Fit-1, Tie-1, 2) (15). Since VEGFis the ligand ofFlk-1 and Fit-1 , we speculated that VEGF had some influence on the differentiation of hemopoietic stem cells, as well as the progenitor of the angiogenic cells. In the present patient, fever and a high level of serum acute inflammatory proteins without any significant evidence of infection may have been due to a high level of serum IL-6. VEGF induces IL-6 production via activation of monocytes. Weinvestigated this case using various methods to disclose the origin of VEGFand IL-6 overproduction, but we could not find any positive results. Wespeculated that macrophages were candidates of the origin of VEGFproduction. Generally, macrophages can produce VEGFand cause angiogenesis (16) . Moreover, macrophages can also promote clotting by exhibiting tissue factor and prothrombinase activity after their activation in vitro ( 17) . This patient suffered from pulmonary embolism and DIC. These hypercoagulable states may have been concerned with tissue factor and prothrombinase, and also with pletelet-derived growth factor and pletelet-activating factor produced from activated macrophages ( 16) .
Several inhibitors of angiogenesis have been used in clinical trials. IFN-oc was used for children's hemangioma to prevent angiogenesis. Nauck et al reported that corticosteroids inhibited the expression of VEGFm-RNAand protein in human smooth muscle cells (18) . This finding suggests that corticosteroids can reduce edemaand prevent angiogenesis in patients with a high serum VEGFlevel. Maruyama et al reported that VEGFprotein production is suppressed by cyclosporin A in vitro (19) . Cyclosporin A inhibits the activity of calcineurin in the cell through tyrosine kinase-related signal transduction. This maybe why cyclosporin Ais effective for patients with angiogenic disease.
The present patient presented a high level of serum VEGF and IL-6 with various clinical symptoms, such as renal failure, pleural effusion, edema, DIC, pulmonary embolism and myelodysplasia. These symptoms could have been caused by angiogenesis, hyperpermeability and hypercoagulation due to a high level of serum VEGF. The kidney and lymph node biopsy findings were swelling of the endocapillary cells and proliferation of the capillary vessels. Cyclosporin A led to clinical remission and was more effective than prednisolone. There was no evidence of diseases such as solid tumors, malignant lymphoma, Castleman's disease or POEMSsyndrome which are reported to have a high serum level of VEGF.Therefore, we speculate that an unknownmechanisminduced the overproduction of VEGFand IL-6.
